
Iil Biologicals Limited
About Iil Biologicals Limited
Data last updated:
Iil Biologicals Limited is a public limited company based in Delhi, India. It operates in the fertilizers and soil enhancers segment of the agriculture sector. It was incorporated on 15 July 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U01100DL2022PLC401834.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Rajesh Kumar Aggarwal and Ritika Pathak.
Its last annual general meeting (AGM) was held on 18 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 407 – 408 Lusa Tower Azadpur Commercial Complex, Delhi, India – 110033.
As per the financials filed for FY 2026, the company reported a revenue of ₹5.79 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹37.36 Lakh (net margin 6.5%) and EBITDA of ₹64.89 Lakh (EBITDA margin 11.2%).
The company has about 1 employee on its provident fund (EPFO) records.
The company has 1 deal on record (1 rights issue); the latest was in December 2022. Its 3 peer companies in the Agriculture industry (Fertilizers, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is Sukiyo International Private Limited with revenue of ₹4.5 Cr.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Iil Biologicals Limited's registered office is in Delhi, Delhi.
- Registered Address407 – 408 Lusa Tower Azadpur Commercial Complex, Delhi, India – 110033
- IndustryAgriculture, Fertilizers & Soil Enhancers, Crop Protection
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Iil Biologicals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Iil Biologicals Limited, buy the company report.
Financials of Iil Biologicals Limited
FY 2026 filings availableIil Biologicals Limited reported revenue of ₹5.79 Cr (up 31% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue rose 31% in the latest year. EBITDA rose 266% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹64.89 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹37.36 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 11.2% | |||
| Net Profit Margin | 6.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Iil Biologicals Limited, buy the company report.
Board of directors of Iil Biologicals Limited
Iil Biologicals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Aggarwal Also directs: Insecticides (India) Limited, Crop Care Federation of India, Oat & Iil India Laboratories Private Limited and 2 more | Director | 15 Jul 2022 | 4 Years 3 Months | Current |
| Ritika Pathak | Director | 15 Jul 2022 | 4 Years 3 Months | Current |
| Sanskar Aggarwal Also directs: Insecticides (India) Limited, Kaeros Research Limited | Director | 15 Jul 2022 | 4 Years 3 Months | Current |
| Anil Kumar Goyal Also directs: Insecticides (India) Limited, Kaeros Research Limited | Director | 24 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Iil Biologicals Limited is compared with the 3 companies closest to it by revenue in the Agriculture industry (Fertilizers, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Iil Biologicals Limitedthis company | ₹5.79 Cr (FY 2026) | ₹37.36 Lakh | 6.5% | 31.0% | Delhi, India | |
| Sukiyo International Private Limited | ₹4.5 Cr (FY 2023) | 2892.0% | Delhi, India | |||
| Vishuddh Organics Private Limited | ₹4.49 Cr (FY 2025) | 15.0% | Ahmedabad, Gujarat, India | |||
| Zebra Organics Fertilizer and Chemicals Private Limited | ₹4.42 Cr (FY 2019) | -13.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Iil Biologicals Limited, buy the company report.
Deals & funding
Iil Biologicals Limited has 1 deal on record (1 rights issue); the latest was in December 2022.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2022 | Rights issue | ₹1.17 Cr | Investors: Insecticides (India) Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Iil Biologicals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Iil Biologicals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Iil Biologicals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Iil Biologicals Limited has 5 board changes on record since 2022: 4 appointments and 1 cessation. The latest: Anil Kumar Goyal ceased to be Additional Director on 11 Jul 2024.
Frequently asked questions
Iil Biologicals is an active public limited company based in Delhi, India. The company works in fertilizers and soil enhancers, within the agriculture industry. It was incorporated on 15 July 2022 (4+ years old) and is registered under CIN U01100DL2022PLC401834.
Iil Biologicals has 4 current directors:
- Rajesh Kumar Aggarwal - Director
- Ritika Pathak - Director
- Sanskar Aggarwal - Director
- Anil Kumar Goyal - Director
The latest financial statements of Iil Biologicals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 18 June 2026. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Iil Biologicals is U01100DL2022PLC401834. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Iil Biologicals was incorporated on 15 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Iil Biologicals has 1 deal on record (1 rights issue); the latest was in December 2022.
The peers of Iil Biologicals by revenue are Sukiyo International Private Limited, Vishuddh Organics Private Limited, Zebra Organics Fertilizer and Chemicals Private Limited, all in the Agriculture industry (Fertilizers, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anil Kumar Goyal ceased to be Additional Director on 11 Jul 2024. Anil Kumar Goyal was appointed as Director on 24 Apr 2024. Rajesh Kumar Aggarwal was appointed as Director on 15 Jul 2022. Iil Biologicals has 5 board changes on record in total.
The registered office of Iil Biologicals is at 407 – 408 Lusa Tower Azadpur Commercial Complex, Delhi, India – 110033.
Iil Biologicals operates in the agriculture industry, in the fertilizers and soil enhancers segment.
The compliance status of Iil Biologicals is compliant as of 02 November 2026. The company is actively filing with the Registrar of Companies.

